A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL

Enrollment

3,219

Participants

Timeline

Start Date

November 16, 2012

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Trajenta tablet

Linagliptin

Trial Locations (1)

Multiple Locations